Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 7,513 articles

Articles by Daniel Marsh

CSL Shares Slide 7.4% as HEMGENIX Scale-Up Faces Supply Constraints
Markets

CSL Shares Slide 7.4% as HEMGENIX Scale-Up Faces Supply Constraints

CSL shares dropped 7.4% last week as HEMGENIX gene therapy progress remains limited, with supply constraints and revenue concerns weighing on the stock.

CSL
CBA Shares Rise as Competitors Outperform in Rate-Driven Rally
Markets

CBA Shares Rise as Competitors Outperform in Rate-Driven Rally

CBA shares rose 1.0% on Friday, trailing rivals Westpac, NAB, and ANZ which averaged a 1.41% gain as investors sought cheaper income plays.

CBAUF ANZBY
Archer Aviation Holds Weekly Gain as Market Awaits Firm Defense Orders
Markets

Archer Aviation Holds Weekly Gain as Market Awaits Firm Defense Orders

Archer Aviation shares ended the week up 7.4%, but a significant portion of Monday's gains evaporated after Halo failed to disclose order pricing, highlighting the need for firm contracts.

ACHR JOBY EVEX
Alibaba Stock Retreats After Qwen Surge, Cloud Margins Now Key Focus
Markets

Alibaba Stock Retreats After Qwen Surge, Cloud Margins Now Key Focus

Alibaba's stock gave back gains from its Qwen model launch, with weekly declines of 2.5% in the US and 4.3% in Hong Kong. Market attention is now on cloud margins.

BABA JD PDD
Arbe Robotics Slips From Defense Rally, Eyes Q2 Earnings
Markets

Arbe Robotics Slips From Defense Rally, Eyes Q2 Earnings

Arbe Robotics (ARBE) stock retreated from a defense-contract rally, closing at $0.6777 with a 6.7% weekly loss. Q2 earnings on August 6 are the next key event.

ARBE MBLY AEVA
CoreWeave Stock Drops 11% as Backlog Conversion Timeline Raises Financing Concerns
Analysis

CoreWeave Stock Drops 11% as Backlog Conversion Timeline Raises Financing Concerns

CoreWeave shares tumbled 11.4% as investors weighed the pace of backlog conversion against a $31-$35 billion capital budget. Microsoft and Meta earnings this week will test demand.

CRWV MSFT META NBIS IREN APLD
HSBC Sells Singapore Insurance Unit at 23x Earnings; Buyback Decision Looms
Markets

HSBC Sells Singapore Insurance Unit at 23x Earnings; Buyback Decision Looms

HSBC has agreed to sell its Singapore insurance business to Allianz for S$2.7 billion, representing 22.9 times projected 2025 earnings, as the bank nears a key capital return decision.

HSBC ALV SPGI
TeraWulf Stock Edges Up Following Lucrative Anthropic AI Lease Deal
Analysis

TeraWulf Stock Edges Up Following Lucrative Anthropic AI Lease Deal

TeraWulf closed Friday at $18.46, down 7.9% on the day but up 1.7% for the week, buoyed by a $19 billion AI lease with Anthropic.

WULF HUT CRWV IREN
SELLAS Life Sciences Stock Tumbles 14% on REGAL Trial Uncertainty
Markets

SELLAS Life Sciences Stock Tumbles 14% on REGAL Trial Uncertainty

SELLAS Life Sciences shares dropped 14% on Friday amid investor caution over the REGAL Phase 3 trial timeline, testing the company's $2.2 billion market cap.

SLS
Cisco Surges Past Nasdaq Despite Light Volume
Markets

Cisco Surges Past Nasdaq Despite Light Volume

Cisco (CSCO) closed at $114.17, up 1.25% on Friday and 2.0% for the week, outperforming the Nasdaq by 4.1 points. However, trading volume was 33% below average, questioning the rally's sustainability.

CSCO ANET AVGO
NuScale Power Stock Edges Higher on Week After $260M Cash Injection
Markets

NuScale Power Stock Edges Higher on Week After $260M Cash Injection

NuScale Power (SMR) shares advanced 4.8% over the week, closing at $8.09 on Friday. The company raised $250.8M from share offerings, covering 96.5% of a $259.9M payment from ENTRA1.

SMR OKLO NNE
Walmart's Valuation Test: Private-Label Push Faces Scrutiny After 4% Weekly Drop
Markets

Walmart's Valuation Test: Private-Label Push Faces Scrutiny After 4% Weekly Drop

Walmart shares fell 4.2% for the week, raising questions about its premium valuation. The retailer's private-label growth strategy faces a key test.

WMT TGT COST AMZN